GLP-1 medications are generally not recommended for patients with type 1 diabetes, those with a personal or family history of medullary thyroid carcinoma, or individuals with multiple endocrine neoplasia syndrome type 2
Improved endothelial function with metformin in type 2 diabetes mellitus
By examining how multiple peptide pathways interact, laboratories can gain deeper insight into complex biological signaling networks
OAT Results (selected abnormal findings): Elevated fumaric acid and citric acid (mitochondrial dysfunction) High pyroglutamic acid (glutathione depletion) Elevated arabinose (yeast overgrowth) Elevated methylmalonate (B12 deficiency) Elevated oxalic acid (possible gut or metabolic stress) Interpretation and Plan: Mitochondrial Support: Added L-carnitine, CoQ10 to support cellular energy
Personalized Medicine Approach In the era of personalized medicine, the decision to use GLP-1 or GIP medications should be tailored to the individuals health status, genetic predispositions, and specific weight loss challenges